QT
CTMX icon

Quantbot Technologies’s CytomX Therapeutics CTMX Stock Holding History

Quantbot Technologies’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Buy
4,687
+3,557
+315% +$13.6K ﹤0.01% 1793
2026
Q1 		$5.31K Buy
+1,130
New +$5.74K ﹤0.01% 1576
2022
Q4 		– Sell
-11,604
Closed -$16K – 1745
2022
Q3 		$16K Buy
11,604
+2,000
+21% +$3.08K ﹤0.01% 1378
2022
Q2 		$17K Sell
9,604
-15,700
-62% -$30.1K ﹤0.01% 1465
2022
Q1 		$67K Buy
25,304
+150
+0.6% +$576 0.01% 1132
2021
Q4 		$108K Buy
+25,154
New +$147K 0.01% 854
2021
Q1 		– Sell
-6,800
Closed -$44K – 1469
2020
Q4 		$44K Buy
+6,800
New +$48.6K ﹤0.01% 878
2020
Q3 		– Sell
-2,600
Closed -$21K – 1344
2020
Q2 		$21K Buy
+2,600
New +$24.1K ﹤0.01% 837
2019
Q4 		– Sell
-5,400
Closed -$39K – 1273
2019
Q3 		$39K Buy
+5,400
New +$53.3K ﹤0.01% 1030
2018
Q4 		– Sell
-4,046
Closed -$74K – 1084
2018
Q3 		$74K Buy
4,046
+1,607
+66% +$36.6K 0.01% 952
2018
Q2 		$55K Buy
+2,439
New +$62.3K ﹤0.01% 970
2018
Q1 		– Sell
-3,115
Closed -$65K – 1257
2017
Q4 		$65K Buy
+3,115
New +$64.6K 0.01% 935

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Quantbot Technologies's CTMX Position: Q2 2026 in Review

Quantbot Technologies increased its CytomX Therapeutics (CTMX) stake by 315% in Q2 2026, buying an estimated $13.6K and bringing the position to 4,687 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Quantbot Technologies first reported a position in CTMX in Q4 2017 and has held it in 12 quarters since. The position peaked at $108K in Q4 2021. 179 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Quantbot Technologies held 4,687 shares of CytomX Therapeutics worth $17.6K as of Q2 2026.
  • Quantbot Technologies bought 3,557 CytomX Therapeutics shares in Q2 2026, an estimated $13.6K.
  • CytomX Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1793 holding.
  • Quantbot Technologies first reported a position in CytomX Therapeutics in Q4 2017 and has held it in 12 quarters since.
  • Quantbot Technologies's CytomX Therapeutics position peaked at $108K in Q4 2021.
  • 179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.